SPANXN4
geneOn this page
Also known as SPANX-N4CT11.9
Summary
SPANXN4 (SPANX family member N4, HGNC:33177) is a protein-coding gene on chromosome Xq27.3, encoding Sperm protein associated with the nucleus on the X chromosome N4 (Q5MJ08).
This gene represents one of several duplicated family members that are located on the X chromosome. This gene family encodes proteins that play a role in spermiogenesis. These proteins represent a specific subgroup of cancer/testis-associated antigens, and they may be candidates for tumor vaccines. This family member belongs to a subgroup of related genes that are present in all primates and rats and mice, and thus, it represents one of the ancestral family members.
Source: NCBI Gene 441525 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 21 total
- MANE Select transcript:
NM_001009613
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33177 |
| Approved symbol | SPANXN4 |
| Name | SPANX family member N4 |
| Location | Xq27.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SPANX-N4, CT11.9 |
| Ensembl gene | ENSG00000189326 |
| Ensembl biotype | protein_coding |
| OMIM | 300667 |
| Entrez | 441525 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000370504, ENST00000446864
RefSeq mRNA: 1 — MANE Select: NM_001009613
NM_001009613
CCDS: CCDS48178
Canonical transcript exons
ENST00000446864 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003978131 | 143034025 | 143034311 |
| ENSE00003978132 | 143025928 | 143026092 |
Expression profiles
Bgee: expression breadth broad, 19 present calls, max score 98.12.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1144 / max 62.2088, expressed in 35 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 197892 | 0.1144 | 35 |
Top tissues by expression
103 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 98.12 | gold quality |
| left testis | UBERON:0004533 | 86.05 | gold quality |
| testis | UBERON:0000473 | 85.28 | gold quality |
| right testis | UBERON:0004534 | 84.38 | gold quality |
| monocyte | CL:0000576 | 68.86 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 66.48 | gold quality |
| leukocyte | CL:0000738 | 65.14 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.31 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| liver | UBERON:0002107 | 28.04 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| muscle of leg | UBERON:0001383 | 26.27 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| gastrocnemius | UBERON:0001388 | 25.36 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.31 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (4): SPANXN3 (ENSG00000189252), SPANXN1 (ENSG00000203923), SPANXN5 (ENSG00000204363), SPANXN2 (ENSG00000268988)
Protein
Protein identifiers
Sperm protein associated with the nucleus on the X chromosome N4 — Q5MJ08 (reviewed: Q5MJ08)
Alternative names: Nuclear-associated protein SPAN-Xn4, SPANX family member N4
All UniProt accessions (2): Q5MJ08, X6R7N2
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the SPAN-X family.
RefSeq proteins (1): NP_001009613* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010007 | SPAN-X_fam | Family |
Pfam: PF07458
UniProt features (7 total): compositionally biased region 4, chain 1, region of interest 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5MJ08-F1 | 69.71 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 1 (showing top):
chrXq27
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
204 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPANXN4 | SPANXA1 | Q9NS26 | 917 |
| SPANXN4 | SPANXD | Q9BXN6 | 655 |
| SPANXN4 | EOLA2 | Q96DE9 | 574 |
| SPANXN4 | XAGE3 | Q8WTP9 | 571 |
| SPANXN4 | CXorf51A | A0A1B0GTR3 | 571 |
| SPANXN4 | TENT5D | Q8NEK8 | 545 |
| SPANXN4 | FAM133A | Q8N9E0 | 541 |
| SPANXN4 | MAGEC3 | Q8TD91 | 480 |
| SPANXN4 | PRR32 | B1ATL7 | 478 |
| SPANXN4 | XAGE1B | Q9HD64 | 473 |
| SPANXN4 | SSX7 | Q7RTT5 | 471 |
| SPANXN4 | XAGE5 | Q8WWM1 | 448 |
| SPANXN4 | EOLA1 | Q8TE69 | 447 |
| SPANXN4 | HSFX4 | A0A1B0GTS1 | 419 |
| SPANXN4 | ZNF157 | P51786 | 417 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SRPK1 | SPANXN4 | psi-mi:“MI:0217”(phosphorylation reaction) | 0.440 |
| CSAG1 | NAP1L4 | psi-mi:“MI:0914”(association) | 0.350 |
| CSAG2 | CAMK2D | psi-mi:“MI:0914”(association) | 0.350 |
| SPANXN4 | UBA6 | psi-mi:“MI:0914”(association) | 0.350 |
| EBAG9 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (54): FTO (Affinity Capture-MS), UBE2R2 (Affinity Capture-MS), INTS9 (Affinity Capture-MS), HNRNPLL (Affinity Capture-MS), GINS1 (Affinity Capture-MS), LANCL2 (Affinity Capture-MS), MAPK1 (Affinity Capture-MS), MAPK3 (Affinity Capture-MS), ADO (Affinity Capture-MS), C9orf41 (Affinity Capture-MS), PNPO (Affinity Capture-MS), RBBP4 (Affinity Capture-MS), MINA (Affinity Capture-MS), PBK (Affinity Capture-MS), SNX27 (Affinity Capture-MS)
ESM2 similar proteins: A0A097SRV6, A0A0J1BDH3, O41801, P04605, P0C1K3, P0C766, P0CG34, P0CG35, P0DX04, P12692, P15633, P15835, P18758, P20065, P21113, P21117, P21752, P21753, P26351, P26352, P33248, P33735, P33736, P33737, P34338, P34493, P53768, P60743, P75605, Q12026, Q4UKT5, Q54CC7, Q55GR5, Q5MJ07, Q5MJ08, Q5VSR9, Q66H17, Q6I7R5, Q6SJ84, Q6SJ91
Diamond homologs: Q0ZNK1, Q5MJ07, Q5MJ08, Q5MJ09, Q5MJ10, Q5VSR9, Q6SJ82, Q6SJ84, Q6SJ91, Q9BXN6, Q9NS26, Q9NY87, Q9NS25
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
21 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 19 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
222 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:143026018:G:GT | donor_gain | 0.9900 |
| X:143026053:G:GT | donor_gain | 0.9900 |
| X:143026085:TTGAC:T | donor_gain | 0.9700 |
| X:143034023:A:AG | acceptor_gain | 0.9700 |
| X:143034024:G:GG | acceptor_gain | 0.9700 |
| X:143026068:A:G | donor_gain | 0.9600 |
| X:143034024:GAA:G | acceptor_gain | 0.9500 |
| X:143026089:CAAGG:C | donor_loss | 0.9400 |
| X:143026090:AAGGT:A | donor_loss | 0.9400 |
| X:143026091:AG:A | donor_loss | 0.9400 |
| X:143026092:G:GT | donor_loss | 0.9400 |
| X:143026093:G:GA | donor_loss | 0.9400 |
| X:143026094:T:A | donor_loss | 0.9400 |
| X:143026087:GACAA:G | donor_loss | 0.9000 |
| X:143034020:A:AG | acceptor_gain | 0.9000 |
| X:143026102:T:G | donor_gain | 0.8600 |
| X:143026107:TTTTG:T | donor_gain | 0.8500 |
| X:143026085:T:G | donor_gain | 0.8400 |
| X:143026088:ACAAG:A | donor_gain | 0.8400 |
| X:143034024:GA:G | acceptor_gain | 0.8400 |
| X:143026018:G:T | donor_gain | 0.8200 |
| X:143034021:C:G | acceptor_gain | 0.8200 |
| X:143034019:TACCA:T | acceptor_loss | 0.7600 |
| X:143034020:ACCAG:A | acceptor_loss | 0.7600 |
| X:143034022:CA:C | acceptor_loss | 0.7600 |
| X:143034024:G:A | acceptor_loss | 0.7600 |
| X:143026116:G:T | donor_gain | 0.7300 |
| X:143034011:T:A | acceptor_loss | 0.7300 |
| X:143034024:GAAGA:G | acceptor_gain | 0.6900 |
| X:143026097:G:C | donor_loss | 0.6800 |
AlphaMissense
659 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:143034106:T:C | F54L | 0.868 |
| X:143034108:T:A | F54L | 0.868 |
| X:143034108:T:G | F54L | 0.868 |
| X:143034117:G:C | R57S | 0.704 |
| X:143034117:G:T | R57S | 0.704 |
| X:143034101:T:C | L52S | 0.686 |
| X:143034104:T:A | V53E | 0.600 |
dbSNP variants (sampled 300 via entrez): RS1000189910 (X:143029464 T>G), RS1000766408 (X:143036431 T>C), RS1001344676 (X:143038182 G>A,T), RS1001780497 (X:143030604 A>C), RS1002099569 (X:143030018 G>A), RS1002191420 (X:143029449 T>C), RS1002350710 (X:143036350 C>A,T), RS1002376429 (X:143028845 T>C), RS1002702352 (X:143032098 GTCT>G), RS1003143247 (X:143032407 G>A), RS1003193148 (X:143027689 C>T), RS1003497747 (X:143027367 G>A), RS1003545251 (X:143025679 G>A), RS1003773237 (X:143034316 T>G), RS1004679782 (X:143033055 C>A)
Disease associations
OMIM: gene MIM:300667 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003804_1 | Non-response to bupropion and depression | 2.000000e-17 |
| GCST006284_6 | Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease | 1.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006899 | PCSK9 protein measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation | 1 |
| Valproic Acid | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): mood disorder